Close
28/05/2015
Synchrotron light applications for the pharmaceutical industry
More than forty people from the pharmaceutical sector attended the workshop organised by the ALBA Synchrotron on May 7.

Researchers from the MSPD, CLAESS, XALOC, NCD and MISTRAL ALBA beam lines have shown the available state-of-the-art techniques and the advantages that they offer in this field: fast data acquisition and shorter experiments, cost savings and, in the case of X-ray microscopy, suppression of ethical conflicts because this technique can be a previous step before clinical essays with animals and persons.

The companies Enantia and Almirall, which have already collaborated with the ALBA Synchrotron, have commented their own experiences at the facility. Enantia, specialised in research solutions for other companies, has detailed different examples. For Almirall, the analysis of polymorphic compounds – performed at ALBA – has increased its quality control, verifying and quantifying purity grades.

News based on the press release issued by the ALBA synchrotron.

Image: ALBA synchrotron. Structure of a herpesvirus nuclease-antiviral complex. Data collected at the Xaloc beam line (Bongarzone, S., Nadal, M. & Coll, M., IBMB)

More news

19/12/2016 ​Foundation stone ceremony for Natura Bissé’s new world headquarters in Barcelona Synchrotron Park 15/12/2016 ​The Bioregion of Catalonia in Nature 07/12/2016 Digitus II Awarded By Barcelona Synchrotron Park As Best Business Idea Of The UAB University Research Park 29/11/2016 ​The European Commission awards the “Business & Biodiversity” label to Barcelona Synchrotron Park 21/11/2016 ​Barcelona 2nd Smart City in the World 15/11/2016 Barcelona Synchrotron Park Sponsors the PRUAB Ideas Generation Program
20 21 22 23 24 25 26 27 28 29 30